Attovia Therapeutics, Inc. (ATTO)

Attovia Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Attovia Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Equivalents	43.3	40.19	30.63
Short-Term Investments	89.33	112.08	38.69
Cash & Cash Equivalents	132.62	152.27	69.32
Cash Growth	-	119.65%	-
Other Current Assets	4.02	4.03	3.16
Total Current Assets	136.64	156.3	72.48
Property, Plant & Equipment	-	3.49	3.23
Goodwill and Intangibles	-	4.37	-
Other Long-Term Assets	-	1.73	1
Total Long-Term Assets	-	9.6	4.23
Total Assets	-	165.89	76.72
Accounts Payable	-	3.55	4.14
Current Debt	-	1.92	-
Other Current Liabilities	9.8	5.54	3.58
Total Current Liabilities	9.8	11.01	7.72
Long-Term Debt	-	3.34	-
Other Long-Term Liabilities	-	0.76	6.87
Total Long-Term Liabilities	-	4.1	6.87
Total Liabilities	-	15.1	14.59
Total Debt	4.8	5.26	0
Retained Earnings	-	-111.01	-50.38
Comprehensive Income	-	0.1	0.07
Shareholders' Equity	-125.52	-107.44	-46.83
Net Cash (Debt)	127.82	147.01	69.32
Net Cash (Debt) Growth	-	112.06%	-
Working Capital	126.84	145.29	64.76